跳至主要内容
临床试验/NCT03715803
NCT03715803已完成不适用

Calistar A vs. Calistar S - Cohort Retrospective Analysis

Agustin Sampietro1 个研究点 分布在 1 个国家目标入组 217 人开始时间: 2018年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
217
试验地点
1
主要终点
Percentage of Cured Participants According to Barber Criteria

研究概览

简要总结

The main objective of this study is to compare the initial outcomes and complication of two meshes implanted through a single incision to treat anterior and apical prolapses, Calistar A and a second-generation low weight mesh called Calistar S (Soft).

详细描述

The main objective of this study is to compare the initial outcomes and complication of two meshes implanted through a single incision to treat anterior and apical prolapses, Calistar A and a second-generation low weight mesh called Calistar S (Soft). In such sense, objective and subjective parameters will be retrospectively tested to demonstrate the safety and effectiveness of this products. Safety will be assessed by register of complications and effectiveness will be evaluated by pelvic floor reconstruction and quality of life improvements.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Anterior and apical prolapse Stage 3 (according to POP-Q) or more with or without stress urinary incontinence (SUI)
  • •Primary or recurrent treatment with Calistar S or Calistar A
  • •At least 6 months follow-up

排除标准

  • •Recurrent vaginal infections,
  • •Chronic colorectal diseases (chronic nonspecific ulcerative colitis, diverticulitis, diverticulosis, Chron's disease, irritable bowel syndrome, familial polyposis).
  • •Presence of any coagulopathies,
  • •Impairment of the immune system or any condition that compromises recovery,
  • •Prior irradiation
  • •Chronic pelvic pain

结局指标

主要结局

Percentage of Cured Participants According to Barber Criteria

时间窗: Post-operative at 6 months

According to Barber criteria cure is defined if there are no points beyond the hymen (measure by POP-Q quantification), an absence of vaginal bulge symptoms and no re-treatment/interventions on year post procedure.

次要结局

  • Adverse Events(Intra-operative and post-operative at 6 months)
  • Percentage of Participants Cured According to Objective Measure (POP-Q Quantification)(Pre-operative and post-operative at 6 months)
  • Quality of Life Status: Patient Global Impression Questionnaire(Post-operative at 6 months)

研究者

发起方
Agustin Sampietro
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Agustin Sampietro

Gynecologist

University of Buenos Aires

研究点 (1)

Loading locations...

相似试验